Viemed Healthcare, Inc. (NASDAQ:VMD) Stake Lifted by Rhumbline Advisers

Rhumbline Advisers increased its stake in Viemed Healthcare, Inc. (NASDAQ:VMD) by 9.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,011 shares of the company’s stock after acquiring an additional 3,613 shares during the period. Rhumbline Advisers owned approximately 0.11% of Viemed Healthcare worth $275,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. lifted its stake in Viemed Healthcare by 53.0% during the first quarter. Vanguard Group Inc. now owns 1,781,914 shares of the company’s stock valued at $16,803,000 after purchasing an additional 617,009 shares during the last quarter. Kent Lake Capital LLC acquired a new stake in Viemed Healthcare during the first quarter valued at approximately $5,557,000. Bard Associates Inc. lifted its stake in Viemed Healthcare by 882.0% during the fourth quarter. Bard Associates Inc. now owns 338,335 shares of the company’s stock valued at $2,656,000 after purchasing an additional 303,880 shares during the last quarter. Penbrook Management LLC lifted its stake in Viemed Healthcare by 236.0% during the second quarter. Penbrook Management LLC now owns 231,607 shares of the company’s stock valued at $1,517,000 after purchasing an additional 162,670 shares during the last quarter. Finally, Salem Investment Counselors Inc. lifted its stake in Viemed Healthcare by 118.8% during the first quarter. Salem Investment Counselors Inc. now owns 72,007 shares of the company’s stock valued at $679,000 after purchasing an additional 39,090 shares during the last quarter. 74.24% of the stock is currently owned by institutional investors.

Viemed Healthcare Stock Up 0.7 %

VMD stock opened at $7.29 on Friday. Viemed Healthcare, Inc. has a 12 month low of $5.90 and a 12 month high of $10.44. The firm has a market cap of $283.07 million, a PE ratio of 28.04 and a beta of 1.47. The firm has a 50 day simple moving average of $7.28 and a 200 day simple moving average of $7.53. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.43 and a quick ratio of 1.29.

Viemed Healthcare (NASDAQ:VMD) last released its earnings results on Wednesday, August 7th. The company reported $0.04 EPS for the quarter, missing the consensus estimate of $0.07 by ($0.03). The business had revenue of $54.97 million for the quarter. Viemed Healthcare had a net margin of 4.60% and a return on equity of 8.23%.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.